Publication | Open Access

MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS Panels

New Resistance MutationsMedicineReceptor Tyrosine KinaseKinase InhibitorsMolecular BiologyResistance Mutation (Virology)PharmacotherapyMet Exon 14PharmacologyDrug DiscoveryDrug Resistance